Author： Currie Graeme Jackson Catherine Lipworth Brian
Publisher： Informa Healthcare
ISSN： 0277-0903
Source： Journal of Asthma, Vol.41, Iss.3, 2004-01, pp. : 247-258
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Bronchial hyperresponsiveness is a fundamental component of the asthmatic inflammatory process causing airway narrowing on exposure to a bronchoconstrictor stimulus. This in turn causes patients to experience symptoms of breathlessness, chest tightness, cough and wheeze. Bronchial challenge tests can be performed in the laboratory to establish the degree of bronchial hyperresponsiveness to both direct and indirect stimuli. The extent to which asthma pharmacotherapy attenuates bronchial hyperresponsiveness is therefore an important measure of efficacy. This review article discusses the effects of inhaled and oral asthma treatment upon bronchial hyperresponsiveness and highlights how, in conjunction with conventional measures of asthma control, it can be used as an aid to optimally manage patients.
Related content
By Wang Junying Mochizuki Hiroyuki Muramatsu Reiko Mizuno Takahisa Arakawa Hirokazu Tokuyama Kenichi Morikawa Akihiro
Journal of Asthma, Vol. 43, Iss. 8, 2006-09 ,pp. :
Access to resources
Recommend
By Agondi Rosana Camara Machado Maria Lavinea Kalil Jorge Giavina-Bianchi Pedro
Journal of Asthma, Vol. 45, Iss. 9, 2008-11 ,pp. :
By Tsurikisawa Naomi Tsuburai Takahiro Oshikata Chiyako Ono Emiko Saito Hiroshi Mitomi Hiroyuki Akiyama Kazuo
Journal of Asthma, Vol. 45, Iss. 6, 2008-08 ,pp. :
By Manso Luis Madero Mauro F. Ruiz-Garcíía Móónica Fernáández-Nieto Mar Sastre Joaquíín
Journal of Asthma, Vol. 48, Iss. 4, 2011-05 ,pp. :